Kainic acid induced hyperexcitability in thalamic reticular nucleus that initiates an inflammatory response through the HMGB1/TLR4 pathway.

[1]  Yung-Yang Lin,et al.  Characterization of Hippocampal-Thalamic-Cortical Morphometric Reorganization in Temporal Lobe Epilepsy , 2022, Frontiers in Neurology.

[2]  J. Munro,et al.  IL-1β induces changes in expression of core circadian clock components PER2 and BMAL1 in primary human chondrocytes through the NMDA receptor/CREB and NF-κB signalling pathways. , 2021, Cellular signalling.

[3]  N. Agarwal,et al.  Neuroprotective Effect of Fisetin Through Suppression of IL-1R/TLR Axis and Apoptosis in Pentylenetetrazole-Induced Kindling in Mice , 2021, Frontiers in Neurology.

[4]  Qidi Ai,et al.  The Anti-Neuroinflammatory Effect of Fuzi and Ganjiang Extraction on LPS-Induced BV2 Microglia and Its Intervention Function on Depression-Like Behavior of Cancer-Related Fatigue Model Mice , 2021, Frontiers in Pharmacology.

[5]  Jianzhong Yin,et al.  Antiepileptic Efficacy and Network Connectivity Modulation of Repetitive Transcranial Magnetic Stimulation by Vertex Suppression , 2021, Frontiers in Human Neuroscience.

[6]  L. Sundstrom,et al.  IL-1β and HMGB1 are anti-neurogenic to endogenous neural stem cells in the sclerotic epileptic human hippocampus , 2021, Journal of Neuroinflammation.

[7]  H. Pass,et al.  HMGB1 as a therapeutic target in disease , 2020, Journal of cellular physiology.

[8]  M. Witter,et al.  The thalamic midline nucleus reuniens: potential relevance for schizophrenia and epilepsy , 2020, Neuroscience & Biobehavioral Reviews.

[9]  J. Muñóz-Valle,et al.  Downregulation of Inflammatory Cytokine Release from IL-1β and LPS-Stimulated PBMC Orchestrated by ST2825, a MyD88 Dimerisation Inhibitor , 2020, Molecules.

[10]  M. Prakriya,et al.  Regulation of chemoconvulsant‐induced seizures by store‐operated Orai1 channels , 2020, The Journal of physiology.

[11]  E. Arslan,et al.  HMGB-1, TLR4, IL-1R1, TNF-α, and IL-1β: novel epilepsy markers? , 2020, Epileptic disorders : international epilepsy journal with videotape.

[12]  Huan Yang,et al.  Targeting Inflammation Driven by HMGB1 , 2020, Frontiers in Immunology.

[13]  M. Jabalameli,et al.  Molecular insights into the role of AMPA receptors in the synaptic plasticity, pathogenesis and treatment of epilepsy: therapeutic potentials of perampanel and antisense oligonucleotide (ASO) technology , 2020, Acta Neurologica Belgica.

[14]  R. Surges,et al.  Time courses of HMGB1 and other inflammatory markers after generalized convulsive seizures , 2020, Epilepsy Research.

[15]  M. Nishibori,et al.  HMGB1 Is a Therapeutic Target and Biomarker in Diazepam-Refractory Status Epilepticus with Wide Time Window , 2019, Neurotherapeutics.

[16]  C. Hang,et al.  The Potassium SK Channel Activator NS309 Protects Against Experimental Traumatic Brain Injury Through Anti-Inflammatory and Immunomodulatory Mechanisms , 2019, Front. Pharmacol..

[17]  Bo Hu,et al.  HMGB1 participates in LPS-induced acute lung injury by activating the AIM2 inflammasome in macrophages and inducing polarization of M1 macrophages via TLR2, TLR4, and RAGE/NF-κB signaling pathways , 2019, International journal of molecular medicine.

[18]  Ayaka Sugiura,et al.  Quantitative analysis of intracranial electrocorticography signals using the concept of statistical parametric mapping , 2019, Scientific Reports.

[19]  Cheng Xu,et al.  Glycyrrhizin mitigates radiation‐induced acute lung injury by inhibiting the HMGB1/TLR4 signalling pathway , 2019, Journal of cellular and molecular medicine.

[20]  A. Vezzani,et al.  Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy , 2019, Nature Reviews Neurology.

[21]  Xueqiang Zhang,et al.  Circulating high mobility group box-1 and toll-like receptor 4 expressions increase the risk and severity of epilepsy , 2019, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[22]  John R. Terry,et al.  Dynamic network properties of the interictal brain determine whether seizures appear focal or generalised , 2019, bioRxiv.

[23]  M. Kim,et al.  Hesperetin, a Citrus Flavonoid, Attenuates LPS-Induced Neuroinflammation, Apoptosis and Memory Impairments by Modulating TLR4/NF-κB Signaling , 2019, Nutrients.

[24]  J. Sander,et al.  Epilepsy in adults , 2019, The Lancet.

[25]  P. Rameshwar,et al.  Exosomes from differentially activated macrophages influence dormancy or resurgence of breast cancer cells within bone marrow stroma , 2019, Cell Death & Disease.

[26]  Iekhsan Othman,et al.  Role of inflammation in epilepsy and neurobehavioral comorbidities: Implication for therapy. , 2018, European journal of pharmacology.

[27]  Iekhsan Othman,et al.  HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction , 2018, Front. Neurosci..

[28]  A. Vezzani,et al.  Pharmacological targeting of brain inflammation in epilepsy: Therapeutic perspectives from experimental and clinical studies , 2018, Epilepsia open.

[29]  S. Orozco-Suárez,et al.  Immunomodulatory effect of Celecoxib on HMGB1/TLR4 pathway in a recurrent seizures model in immature rats , 2018, Pharmacology Biochemistry and Behavior.

[30]  E. Aronica,et al.  Review: Neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies , 2018, Neuropathology and applied neurobiology.

[31]  J. Teng,et al.  HMGB1 mediates microglia activation via the TLR4/NF-κB pathway in coriaria lactone induced epilepsy , 2018, Molecular medicine reports.

[32]  Jie Hu,et al.  The Large Conductance Calcium- and Voltage-activated Potassium Channel (BK) and Epilepsy. , 2018, CNS & neurological disorders drug targets.

[33]  Yu-Ping Wang,et al.  MicroRNA-129-5p inhibits the development of autoimmune encephalomyelitis-related epilepsy by targeting HMGB1 through the TLR4/NF-kB signaling pathway , 2017, Brain Research Bulletin.

[34]  Annika Lüttjohann,et al.  Absence Seizure Control by a Brain Computer Interface , 2017, Scientific Reports.

[35]  B. Leitch,et al.  NMDA Receptor Expression in the Thalamus of the Stargazer Model of Absence Epilepsy , 2017, Scientific Reports.

[36]  M. Manford Recent advances in epilepsy , 2017, Journal of Neurology.

[37]  S. Shultz,et al.  Inflammation in epileptogenesis after traumatic brain injury , 2017, Journal of Neuroinflammation.

[38]  S. Santillo,et al.  AMPA/NMDA cooperativity and integration during a single synaptic event , 2016, Journal of Computational Neuroscience.

[39]  Jianxiong Jiang,et al.  Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside. , 2016, Trends in pharmacological sciences.

[40]  A. Vezzani,et al.  Modulation of neuronal excitability by immune mediators in epilepsy. , 2016, Current opinion in pharmacology.

[41]  Laura D. Lewis,et al.  Thalamic reticular nucleus induces fast and local modulation of arousal state , 2015, eLife.

[42]  Ja-Kyeong Lee,et al.  Glycyrrhizin Suppresses HMGB1 Inductions in the Hippocampus and Subsequent Accumulation in Serum of a Kainic Acid-Induced Seizure Mouse Model , 2014, Cellular and Molecular Neurobiology.

[43]  E. Aronica,et al.  The inflammatory molecules IL-1β and HMGB1 can rapidly enhance focal seizure generation in a brain slice model of temporal lobe epilepsy , 2014, Front. Cell. Neurosci..

[44]  Liping Yu,et al.  Purified monomeric ligand.MD-2 complexes reveal molecular and structural requirements for activation and antagonism of TLR4 by Gram-negative bacterial endotoxins , 2014, Immunologic Research.

[45]  D. Janigro,et al.  Inflammatory pathways of seizure disorders , 2014, Trends in Neurosciences.

[46]  C. Garlanda,et al.  The interleukin-1 family: back to the future. , 2013, Immunity.

[47]  E. Aronica,et al.  Epilepsy and brain inflammation , 2013, Experimental Neurology.

[48]  E. Aronica,et al.  Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures , 2010, Nature Medicine.

[49]  L. Zhang,et al.  Rebound bursts in GABAergic neurons of the thalamic reticular nucleus in postnatal mice. , 2010, Physiological research.

[50]  I. Singh,et al.  Statin inhibits kainic acid-induced seizure and associated inflammation and hippocampal cell death , 2008, Neuroscience Letters.

[51]  J. Hablitz,et al.  Calcium release via activation of presynaptic IP3 receptors contributes to kainate-induced IPSC facilitation in rat neocortex , 2008, Neuropharmacology.

[52]  C. Mahaffey,et al.  Absence seizures in C3H/HeJ and knockout mice caused by mutation of the AMPA receptor subunit Gria4 , 2008, Human molecular genetics.

[53]  Y. Cakmak,et al.  The pathways connecting the hippocampal formation, the thalamic reuniens nucleus and the thalamic reticular nucleus in the rat , 2008, Journal of anatomy.

[54]  S. Vicini,et al.  Presynaptic AMPA and kainate receptors increase the size of GABAergic terminals and enhance GABA release , 2007, Neuropharmacology.

[55]  E. Roubos,et al.  NMDA-NR1 and AMPA-GluR4 receptor subunit immunoreactivities in the absence epileptic WAG/Rij rat , 2006, Epilepsy Research.

[56]  D. Bayliss,et al.  Different kinetic properties of two T‐type Ca2+ currents of rat reticular thalamic neurones and their modulation by enflurane , 2005, The Journal of physiology.

[57]  Seung Bong Hong,et al.  Cerebral perfusion changes in mesial temporal lobe epilepsy: SPM analysis of ictal and interictal SPECT , 2005, NeuroImage.

[58]  A. Fisahn,et al.  Kainate receptors and rhythmic activity in neuronal networks: hippocampal gamma oscillations as a tool , 2005, The Journal of physiology.

[59]  Liming Zhang,et al.  Corticothalamic inhibition in the thalamic reticular nucleus. , 2004, Journal of neurophysiology.

[60]  M. Nedergaard,et al.  A Kainate Receptor Increases the Efficacy of GABAergic Synapses , 2001, Neuron.

[61]  Y. Ben-Ari,et al.  Kainate, a double agent that generates seizures: two decades of progress , 2000, Trends in Neurosciences.

[62]  P. Bergold,et al.  Hyperexcitability and cell loss in kainate‐treated hippocampal slice cultures , 1993, Neuroreport.

[63]  B. Connors,et al.  Thalamocortical responses of mouse somatosensory (barrel) cortexin vitro , 1991, Neuroscience.